|Bid||4.5000 x 800|
|Ask||5.4000 x 1000|
|Day's Range||4.7500 - 5.0550|
|52 Week Range||3.1050 - 11.9300|
|Beta (5Y Monthly)||1.20|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Kindred Biosciences, Inc. ( NASDAQ:KIN ) shareholders should be happy to see the share price up 16% in the last month...
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks aren’t doing […]
This article will reflect on the compensation paid to Richard Chin who has served as CEO of Kindred Biosciences, Inc...